Literature DB >> 28954902

Implementation of a Clinical Decision Support Tool for Stool Cultures and Parasitological Studies in Hospitalized Patients.

D Nikolic1, S S Richter1, K Asamoto1, R Wyllie2, R Tuttle1, G W Procop3,2.   

Abstract

There is substantial evidence that stool culture and parasitological examinations are of minimal to no value after 3 days of hospitalization. We implemented and studied the impact of a clinical decision support tool (CDST) to decrease the number of unnecessary stool cultures (STCUL), ova/parasite (O&P) examinations, and Giardia/Cryptosporidium enzyme immunoassay screens (GC-EIA) performed for patients hospitalized >3 days. We studied the frequency of stool studies ordered before or on day 3 and after day 3 of hospitalization (i.e., categorical orders/total number of orders) before and after this intervention and denoted the numbers and types of microorganisms detected within those time frames. This intervention, which corresponded to a custom-programmed hard-stop alert tool in the Epic hospital information system, allowed providers to override the intervention by calling the laboratory, if testing was deemed medically necessary. Comparative statistics were employed to determine significance, and cost savings were estimated based on our internal costs. Before the intervention, 129/670 (19.25%) O&P examinations, 47/204 (23.04%) GC-EIA, and 249/1,229 (20.26%) STCUL were ordered after 3 days of hospitalization. After the intervention, 46/521 (8.83%) O&P examinations, 27/157 (17.20%) GC-EIA, and 106/1,028 (10.31%) STCUL were ordered after 3 days of hospitalization. The proportions of reductions in the number of tests performed after 3 days and the associated P values were 54.1% for O&P examinations (P < 0.0001), 22.58% for GC-EIA (P = 0.2807), and 49.1% for STCUL (P < 0.0001). This was estimated to have resulted in $8,108.84 of cost savings. The electronic CDST resulted in a substantial reduction in the number of evaluations of stool cultures and the number of parasitological examinations for patients hospitalized for more than 3 days and in a cost savings while retaining the ability of the clinician to obtain these tests if clinically indicated.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  O&P examinations; stewardship; stool culture; utilization

Mesh:

Year:  2017        PMID: 28954902      PMCID: PMC5703801          DOI: 10.1128/JCM.01052-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Yield from stool testing of pediatric inpatients.

Authors:  S B Meropol; A A Luberti; A R De Jong
Journal:  Arch Pediatr Adolesc Med       Date:  1997-02

2.  Variation among physicians in use of laboratory tests. II. Relation to clinical productivity and outcomes of care.

Authors:  M Daniels; S A Schroeder
Journal:  Med Care       Date:  1977-06       Impact factor: 2.983

3.  Reducing duplicate testing: a comparison of two clinical decision support tools.

Authors:  Gary W Procop; Catherine Keating; Paul Stagno; Kandice Kottke-Marchant; Mary Partin; Robert Tuttle; Robert Wyllie
Journal:  Am J Clin Pathol       Date:  2015-05       Impact factor: 2.493

4.  Improving Molecular Genetic Test Utilization through Order Restriction, Test Review, and Guidance.

Authors:  Jacquelyn D Riley; Gary W Procop; Kandice Kottke-Marchant; Robert Wyllie; Felicitas L Lacbawan
Journal:  J Mol Diagn       Date:  2015-02-27       Impact factor: 5.568

5.  Validation of the 3-day rule for stool bacterial tests in Japan.

Authors:  Masanori Kobayashi; Akahito Sako; Toshiko Ogami; So Nishimura; Naoki Asayama; Tomoyuki Yada; Naoyoshi Nagata; Toshiyuki Sakurai; Chizu Yokoi; Masao Kobayakawa; Mikio Yanase; Naohiko Masaki; Nozomi Takeshita; Naomi Uemura
Journal:  Intern Med       Date:  2014       Impact factor: 1.271

Review 6.  Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile.

Authors:  Christopher R Polage; Jay V Solnick; Stuart H Cohen
Journal:  Clin Infect Dis       Date:  2012-06-14       Impact factor: 9.079

Review 7.  Rationale for cost-effective laboratory medicine.

Authors:  A Robinson
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

Review 8.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

9.  Application of rejection criteria for stool ovum and parasite examinations.

Authors:  A J Morris; M L Wilson; L B Reller
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

Review 10.  The Meaning of Health in the Era of Value-based Care.

Authors:  Joseph E Balog
Journal:  Cureus       Date:  2017-02-21
View more
  4 in total

1.  Efficacy and unintended consequences of hard-stop alerts in electronic health record systems: a systematic review.

Authors:  Emily M Powers; Richard N Shiffman; Edward R Melnick; Andrew Hickner; Mona Sharifi
Journal:  J Am Med Inform Assoc       Date:  2018-11-01       Impact factor: 4.497

2.  Optimizing Test Utilization in the Clinical Microbiology Laboratory: Tools and Opportunities.

Authors:  Bobbi S Pritt
Journal:  J Clin Microbiol       Date:  2017-09-27       Impact factor: 5.948

3.  Reply to Beal et al., 'The "3-Day Rule" for Stool Tests May Not Apply When Using PCR Panels'.

Authors:  G W Procop; D Nikolic; K Asamoto; R Wyllie; R Tuttle; S S Richter
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

4.  The "3-Day Rule" for Stool Tests May Not Apply When Using PCR Panels.

Authors:  Stacy G Beal; Lymaries Velez; Elizabeth E Tremblay; Steven Toffel; Kenneth H Rand
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.